Report Scope
This report analyzes the global contract research organization (CRO) services market and will cover all the major global CRO companies. It provides a comprehensive overview of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service offerings.

As part of this analysis, the CRO services market is divided by functional services into the following market segments: clinical trials services, preclinical research, drug discovery and central lab. It is segmented by therapeutic area into the following markets: oncology, cardiology, metabolic, neurology, immunology and other applications (such as CNS, respiratory and genetic diseases). Based on end user, it is segmented into biopharmaceutical companies as well as academic research institutions.

The global CRO services market is also segmented by geography into these regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The regional analysis includes a detailed examination of the major countries operating in this market such as the U.S., Germany, the U.K., France, Japan, China and India.

This report analyzes the market trends associated with CRO services using data from 2023, which serves as the base year. Market estimates are provided for 2024, and forecasts of compound annual growth rates are given for the period 2024 through 2029. The report will also highlight the current and future potential of the CRO services market, and will give a detailed analysis of this market’s competitive landscape by covering regulatory scenarios, drivers, restraints and opportunities, as well as the market share of key players.

Emerging trends and changing market dynamics within the CRO industry are also analyzed in detail in this report.

This report’s goals include:

  • Analyzing technologies and applications.
  • Analyzing global market size and segmentation.
  • Understanding market constraints and drivers.
  • Providing detailed market forecasts through 2029.
  • Assessing market shares, competitiveness and industry structure.
  • Identifying potential long-term impacts on the CRO services market.


Report Includes

  • 86 data tables and 33 additional tables
  • An overview of the current and future global market for contract research organization (CRO) services
  • Analyses of global market trends, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
  • Estimates of the market size and revenue forecasts for the global CRO market, with market share analysis based on functional services, therapeutic area, end user, and region
  • Information on CDISC standards, and regulations on sponsor activities; discussion of the impact of FDA regulations on the pharmaceutical industry and the potential long-term impacts of CROs on the drug discovery technologies market
  • Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
  • Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
  • Profiles of the leading companies, including IQVIA Inc., PPD Inc., ICON plc., Charles River Laboratories International Inc., and LabCorp.